Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Bookmark(0)

Rheumatology teams care for patients with diverse, systemic autoimmune diseases who are often immunosuppressed and at high risk of infections. The current COVID-19 pandemic has presented particular challenges in caring […]

» Read more

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Bookmark(0)

Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course […]

» Read more

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Bookmark(0)

Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant […]

» Read more

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Bookmark(0)

To provide guidance to rheumatology providers on the management of adult rheumatic disease patients in the context of the COVID-19 pandemic.A task force, including 10 rheumatologists and 4 infectious diseases […]

» Read more

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: ‘Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India’ by Gupta et al and ‘Antirheumatic agents in covid-19: is IL-6 the right target?’ by Capeechi et al.

Bookmark(0)

Click here to read the full article @ Annals of the rheumatic diseases

» Read more

[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/CovidĀ 19 pandemic].

Bookmark(0)

In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these questions cannot yet be answered on an evidence-based […]

» Read more

The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.

Bookmark(0)

We appreciate our Italian colleagues’ interest in our editorial denoting the rheumatologist’s role in helping to diagnose and treat cytokine storm syndrome (CSS) in the setting of the Covid-19 panemic […]

» Read more